Bolt Biotherapeutics Inc. Revenue 2020–2025
Bolt Biotherapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bolt Biotherapeutics Inc. revenue for the quarter ending March 31, 2026 was 26000, a 97.87% decrease year-over-year.
- Bolt Biotherapeutics Inc. revenue for the twelve months ending March 31, 2026 was 5.2 M, a 48.90% decrease year-over-year.
- Bolt Biotherapeutics Inc. annual revenue for 2025 was 7.7 M, a 0.07% increase from 2024.
- Bolt Biotherapeutics Inc. annual revenue for 2024 was 7.7 M, a 2.36% decrease from 2023.
- Bolt Biotherapeutics Inc. annual revenue for 2023 was 7.9 M, a 37.48% increase from 2022.
- Bolt Biotherapeutics Inc. annual revenue for 2022 was 5.7 M.
Bolt Biotherapeutics Inc. (BOLT) — Frequently Asked Questions
Bolt Biotherapeutics Inc. (BOLT) is a publicly traded US company. It has a market capitalization of $8M. In fiscal 2025 it reported revenue of $8M and net income of -$33M. Explore BOLT's stock price, financial statements, earnings history, margins and key ratios below.
What is Bolt Biotherapeutics Inc.'s market cap?
Bolt Biotherapeutics Inc. (BOLT) has a market capitalization of $8M.
What is the BOLT stock price?
BOLT trades at $4.43 (-4.11% on the day).
How much revenue does Bolt Biotherapeutics Inc. make?
Bolt Biotherapeutics Inc. reported revenue of $8M in fiscal 2025.
Is BOLT profitable?
In fiscal 2025, Bolt Biotherapeutics Inc. reported net income of -$33M.